April 2023

U.S. Trade Representative cites Canada’s “IP problems” including pharmaceutical patent protection

By Kristin Wall & Paul Jorgensen on April 27, 2023

On April 26, 2023, the Office of the United States Trade Representative (USTR) released its 2023 Special 301 Report on intellectual property. The report keeps Canada on a Watch List of 29 U.S. trading partners that “merit bilateral attention…

Federal Court of Appeal rejects elevated standard of proof for induced infringement in paliperidone case

By Kristin Wall, Christopher A. Guerreiro & Pharma in Brief team on April 21, 2023

The Federal Court of Appeal (FCA) has allowed an appeal concerning induced infringement in an action under the Patented Medicines (Notice of Compliance) Regulations (Regulations). The FCA found that the Federal Court (FC) had…

Pharma in Brief

April 2023

U.S. Trade Representative cites Canada’s “IP problems” including pharmaceutical patent protection

Federal Court of Appeal rejects elevated standard of proof for induced infringement in paliperidone case

About

Topics

Archives